Small Cap Active Stocks: FuelCell Energy (NASDAQ:FCEL), Ariad Pharmaceuticals (NASDAQ:ARIA), KB Home (NYSE:KBH), Endocyte (NASDAQ:ECYT)

Shares of Plug Power Inc. (NASDAQ:FCEL) fell 9% on Friday, and the stock was moving toward ending the week down nearly 20% as investors’ enthusiasm for it seemed to have dried up — at least for now. FuelCell Energy Inc (NASDAQ:FCEL) stock performance was 6.64% in last session and finished the day at $2.57. Traded volume was 29.87million shares in the last session and the … Continue reading Small Cap Active Stocks: FuelCell Energy (NASDAQ:FCEL), Ariad Pharmaceuticals (NASDAQ:ARIA), KB Home (NYSE:KBH), Endocyte (NASDAQ:ECYT)

Trending Tickers : Halliburton Company (NYSE:HAL), ArcelorMittal SA (ADR) (NYSE:MT), Columbia Property Trust, Inc. (NYSE:CXP), Coherent Inc. (NASDAQ:COHR), Endocyte, Inc. (NASDAQ:ECYT)

On Oct 21, As fracking accelerates in North American shale fields, oilfield services providers Halliburton Company (NYSE:HAL) and Baker Hughes Inc are stockpiling sand to protect themselves against rising costs and are buying more railcars to transport the haul. Halliburton Company (NYSE:HAL) belongs to Basic Materials sector. Its net profit margin is 10.70% and weekly performance is -1.00%. On last trading day company shares ended … Continue reading Trending Tickers : Halliburton Company (NYSE:HAL), ArcelorMittal SA (ADR) (NYSE:MT), Columbia Property Trust, Inc. (NYSE:CXP), Coherent Inc. (NASDAQ:COHR), Endocyte, Inc. (NASDAQ:ECYT)

Trader’s Watch List: Amicus Therapeutics, Inc. (NASDAQ:FOLD), Chesapeake Energy Corporation (NYSE:CHK), Envivio, Inc. (NASDAQ:ENVI), Mannatech, Incorporated (NASDAQ:MTEX), Endocyte, Inc. (NASDAQ:ECYT)

Amicus Therapeutics (NASDAQ:FOLD) COO Bradley L. Campbell unloaded 18,750 shares of the company’s stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $5.40, for a total transaction of $101,250.00. Following the completion of the transaction, the chief operating officer now directly owns 200,000 shares in the company, valued at approximately $1,080,000. Amicus Therapeutics, Inc. (NASDAQ:FOLD) … Continue reading Trader’s Watch List: Amicus Therapeutics, Inc. (NASDAQ:FOLD), Chesapeake Energy Corporation (NYSE:CHK), Envivio, Inc. (NASDAQ:ENVI), Mannatech, Incorporated (NASDAQ:MTEX), Endocyte, Inc. (NASDAQ:ECYT)

NASDAQ Losers: ON Semiconductor Corp (NASDAQ:ONNN), Endocyte (NASDAQ:ECYT), Actuate Corp (NASDAQ:BIRT), Merrimack Pharmaceuticals (NASDAQ:MACK)

ON Semiconductor Corp (NASDAQ:ONNN)’s adjusted earnings totaled $75.2 million, or 17 cents a share, while revenue increased year over year to $706.5 million from $661 million. Analysts polled by Thomson Reuters expected the company to earn 15 cents a share on revenue of $711.67 million. The company issued second-quarter revenue guidance in the range of $738 million to $768 million. ON Semiconductor Corp (NASDAQ:ONNN) stock … Continue reading NASDAQ Losers: ON Semiconductor Corp (NASDAQ:ONNN), Endocyte (NASDAQ:ECYT), Actuate Corp (NASDAQ:BIRT), Merrimack Pharmaceuticals (NASDAQ:MACK)

Gilead Sciences GILD NASDAQ:GILD

Active Stocks: Endocyte (NASDAQ:ECYT), Gilead Sciences, Inc. (NASDAQ:GILD), Arena Pharmaceuticals (NASDAQ:ARNA), Immunomedics (NASDAQ:IMMU)

Endocyte (NASDAQ:ECYT)’s shares saw strong trading volume on Friday after the company announced better than expected quarterly earnings, American Banking and Market News reports. 13,778,961 shares changed hands during trading, an increase of 624% from the previous session’s volume of 1,903,723 shares. Endocyte, Inc. (NASDAQ:ECYT) stock performance was 61.91% in last session and finished the day at $ 6.62. Traded volume was 17,639,435 shares in … Continue reading Active Stocks: Endocyte (NASDAQ:ECYT), Gilead Sciences, Inc. (NASDAQ:GILD), Arena Pharmaceuticals (NASDAQ:ARNA), Immunomedics (NASDAQ:IMMU)

Biotech Gainers: Xencor Inc (NASDAQ:XNCR), Pacific Biosciences of California (NASDAQ:PACB), Endocyte (NASDAQ:ECYT), Incyte Corporation (NASDAQ:INCY)

Xencor, Inc. (NASDAQ:XNCR) is unchanged at $11.73, with 934,368 shares traded. As reported by Zacks, the current mean recommendation for XNCR is in the “strong buy range”. Xencor Inc (NASDAQ:XNCR) stock performance was 11.18% in last session and finished the day at $11.73. Traded volume was 1.86million shares in the last session and the average volume of the stock remained 132.02K shares. Xencor Inc (NASDAQ:XNCR) … Continue reading Biotech Gainers: Xencor Inc (NASDAQ:XNCR), Pacific Biosciences of California (NASDAQ:PACB), Endocyte (NASDAQ:ECYT), Incyte Corporation (NASDAQ:INCY)